Bio-Rad Laboratories Class A

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIO and other ETFs, options, and stocks.

About BIO

Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics. 

CEO
Norman D. Schwartz
CEONorman D. Schwartz
Employees
7,450
Employees7,450
Headquarters
Hercules, California
HeadquartersHercules, California
Founded
1952
Founded1952
Employees
7,450
Employees7,450

BIO Key Statistics

Market cap
10.38B
Market cap10.38B
Price-Earnings ratio
46.78
Price-Earnings ratio46.78
Dividend yield
Dividend yield
Average volume
237.42K
Average volume237.42K
High today
$386.78
High today$386.78
Low today
$376.20
Low today$376.20
Open price
$380.84
Open price$380.84
Volume
81.78K
Volume81.78K
52 Week high
$396.23
52 Week high$396.23
52 Week low
$236.73
52 Week low$236.73

Stock Snapshot

Bio-Rad Laboratories Class A(BIO) stock is priced at $386.12, giving the company a market capitalization of 10.38B. It carries a P/E multiple of 46.78.

During the trading session on 2026-09-05, Bio-Rad Laboratories Class A(BIO) shares reached a daily high of $386.78 and a low of $376.20. At a current price of $386.12, the stock is +2.6% higher than the low and still -0.2% under the high.

Trading activity shows a volume of 81.78K, compared to an average daily volume of 237.42K.

Over the past 52 weeks, Bio-Rad Laboratories Class A(BIO) stock has traded between a high of $396.23 and a low of $236.73.

Over the past 52 weeks, Bio-Rad Laboratories Class A(BIO) stock has traded between a high of $396.23 and a low of $236.73.

BIO News

Simply Wall St 5d
Bio Rad Laboratories Rebound Puts Fair Value Questions Back In Focus

Advertisement Fresh look at Bio-Rad Laboratories after recent share price move Bio-Rad Laboratories (BIO) has drawn fresh investor attention after a recent sh...

Bio Rad Laboratories Rebound Puts Fair Value Questions Back In Focus

Analyst ratings

57%

of 7 ratings
Buy
14.3%
Hold
57.1%
Sell
28.6%

People also own

Based on the portfolios of people who own BIO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.